【Breaking News】Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.'s independently developed active pharmaceutical ingredient (API) Cliborol (Registr...

We are proud to announce that our pharmaceutical ingredient Tetracaine Hydrochloride has been granted the Certificate of Suitability to the European ...

Shandong Chenghui Pharma Group cordially invites you to attend CPHI & PMEC Pharmaceutical Industry Exhibition (Shenzhen), which will be held grandly ...

From 1 to 3 September 2025, Shandong Chenghui Pharmaceutical Group & Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. will showcase their hi...

Shanghai, June 26, 2025‌ – The three-day CPHI China exhibition concluded successfully at the Shanghai New International Expo Centre. Shandong Chenghu...

CPHI China 2025: Shandong Chenghui Pharmaceutical Group to Showcase Innovations at Booth W1A30 The global pharmaceutical industry's ...

‌Guangzhou in May was bustling with energy as Shandong Chenghui Pharmaceutical Group showcased its innovative pharmaceutical intermediates and spec...

‌Shandong Chenghui Pharmaceutical Group sincerely invites you to visit ‌the 92nd API China Exhibition‌ (Booth No.: 10.3E10) to explore new trends in...